7-152252613-G-T

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBS1BS2

The NM_170606.3(KMT2C):​c.1402C>A​(p.Pro468Thr) variant causes a missense change. The variant allele was found at a frequency of 0.00131 in 1,613,302 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P468A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0010 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0013 ( 2 hom. )

Consequence

KMT2C
NM_170606.3 missense

Scores

2
13
2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:3O:1

Conservation

PhyloP100: 5.71

Publications

10 publications found
Variant links:
Genes affected
KMT2C (HGNC:13726): (lysine methyltransferase 2C) This gene is a member of the myeloid/lymphoid or mixed-lineage leukemia (MLL) family and encodes a nuclear protein with an AT hook DNA-binding domain, a DHHC-type zinc finger, six PHD-type zinc fingers, a SET domain, a post-SET domain and a RING-type zinc finger. This protein is a member of the ASC-2/NCOA6 complex (ASCOM), which possesses histone methylation activity and is involved in transcriptional coactivation. [provided by RefSeq, Jul 2008]
KMT2C Gene-Disease associations (from GenCC):
  • Kleefstra syndrome 2
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Illumina, Ambry Genetics, Broad Center for Mendelian Genomics
  • syndromic intellectual disability
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.18792519).
BP6
Variant 7-152252613-G-T is Benign according to our data. Variant chr7-152252613-G-T is described in ClinVar as Likely_benign. ClinVar VariationId is 134737.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000998 (152/152304) while in subpopulation NFE AF = 0.00191 (130/68030). AF 95% confidence interval is 0.00164. There are 0 homozygotes in GnomAd4. There are 68 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 152 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_170606.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KMT2C
NM_170606.3
MANE Select
c.1402C>Ap.Pro468Thr
missense
Exon 10 of 59NP_733751.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KMT2C
ENST00000262189.11
TSL:1 MANE Select
c.1402C>Ap.Pro468Thr
missense
Exon 10 of 59ENSP00000262189.6
KMT2C
ENST00000682283.1
c.1402C>Ap.Pro468Thr
missense
Exon 10 of 60ENSP00000507485.1
KMT2C
ENST00000679882.1
c.1402C>Ap.Pro468Thr
missense
Exon 10 of 56ENSP00000506154.1

Frequencies

GnomAD3 genomes
AF:
0.000999
AC:
152
AN:
152186
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000290
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000327
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000942
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00191
Gnomad OTH
AF:
0.00144
GnomAD2 exomes
AF:
0.000757
AC:
190
AN:
250888
AF XY:
0.000745
show subpopulations
Gnomad AFR exome
AF:
0.000185
Gnomad AMR exome
AF:
0.000203
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000927
Gnomad NFE exome
AF:
0.00155
Gnomad OTH exome
AF:
0.000327
GnomAD4 exome
AF:
0.00134
AC:
1960
AN:
1460998
Hom.:
2
Cov.:
30
AF XY:
0.00132
AC XY:
959
AN XY:
726832
show subpopulations
African (AFR)
AF:
0.000120
AC:
4
AN:
33454
American (AMR)
AF:
0.000157
AC:
7
AN:
44702
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26130
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39664
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86242
European-Finnish (FIN)
AF:
0.0000937
AC:
5
AN:
53336
Middle Eastern (MID)
AF:
0.000521
AC:
3
AN:
5760
European-Non Finnish (NFE)
AF:
0.00170
AC:
1893
AN:
1111344
Other (OTH)
AF:
0.000795
AC:
48
AN:
60366
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.456
Heterozygous variant carriers
0
86
172
258
344
430
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
68
136
204
272
340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000998
AC:
152
AN:
152304
Hom.:
0
Cov.:
32
AF XY:
0.000913
AC XY:
68
AN XY:
74468
show subpopulations
African (AFR)
AF:
0.000289
AC:
12
AN:
41572
American (AMR)
AF:
0.000327
AC:
5
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.0000942
AC:
1
AN:
10612
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00191
AC:
130
AN:
68030
Other (OTH)
AF:
0.00142
AC:
3
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
6
13
19
26
32
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00136
Hom.:
0
Bravo
AF:
0.000756
TwinsUK
AF:
0.00216
AC:
8
ALSPAC
AF:
0.00234
AC:
9
ESP6500AA
AF:
0.000681
AC:
3
ESP6500EA
AF:
0.00186
AC:
16
ExAC
AF:
0.000857
AC:
104
EpiCase
AF:
0.00136
EpiControl
AF:
0.00166

ClinVar

Significance: Likely benign
Submissions summary: Benign:3Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Nov 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

KMT2C: BS1

Jan 07, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Other:1
Sep 19, 2013
ITMI
Significance:not provided
Review Status:no classification provided
Collection Method:reference population

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.51
BayesDel_addAF
Uncertain
0.032
T
BayesDel_noAF
Pathogenic
0.27
CADD
Benign
23
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.50
T
Eigen
Uncertain
0.50
Eigen_PC
Uncertain
0.60
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Uncertain
0.88
D
M_CAP
Benign
0.060
D
MetaRNN
Benign
0.19
T
MetaSVM
Uncertain
0.15
D
MutationAssessor
Uncertain
2.4
M
PhyloP100
5.7
PrimateAI
Uncertain
0.71
T
PROVEAN
Uncertain
-4.3
D
REVEL
Uncertain
0.55
Sift
Uncertain
0.013
D
Polyphen
0.79
P
Vest4
0.91
MVP
0.79
MPC
0.28
ClinPred
0.073
T
GERP RS
6.0
PromoterAI
-0.0080
Neutral
Varity_R
0.18
gMVP
0.59
Mutation Taster
=75/25
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs140919432; hg19: chr7-151949698; API